The Complement Pathway Is Activated in People With Human Immunodeficiency Virus and Is Associated With Non-AIDS Comorbidities
Open Access
- 19 February 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 224 (8), 1405-1409
- https://doi.org/10.1093/infdis/jiab096
Abstract
Unbiased plasma proteomics in a matched case-control study of treated people with HIV (PWH) revealed the complement cascade as being among the top pathways enriched in PWH. Specific complement components, namely C5, associated significantly with non-AIDS comorbidity prevalence, and did so more strongly than previously established predictive biomarkers.Keywords
Funding Information
- Netherlands Organization for Health Research and Development (300020007)
- Aids Fonds (2009063)
- National Institutes of Health
This publication has 15 references indexed in Scilit:
- Serum concentrations of TNF-α and its soluble receptors in Graves’ diseaseEndocrine Connections, 2020
- Complement and the Regulation of T Cell ResponsesAnnual Review of Immunology, 2018
- The inflammatory effects of TNF-α and complement component 3 on coagulationScientific Reports, 2018
- Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsisProceedings of the National Academy of Sciences of the United States of America, 2017
- Soluble CD14 is a nonspecific marker of monocyte activationAIDS, 2015
- Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort StudyClinical Infectious Diseases, 2014
- Soluble Markers of Inflammation and Coagulation but Not T-Cell Activation Predict Non–AIDS-Defining Morbid Events During Suppressive Antiretroviral TreatmentThe Journal of Infectious Diseases, 2014
- Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV InfectionThe Journal of Infectious Diseases, 2014
- Regulatory role of C5a in LPS‐induced IL‐6 production by neutrophils during sepsisThe FASEB Journal, 2003
- Anti-C5a Ameliorates Coagulation/Fibrinolytic Protein Changes in a Rat Model of SepsisThe American Journal of Pathology, 2002